Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for Antipsychotic-induced Weight Gain in Adults With Intellectual Disability
NCT05744479Phase 4Recruiting
- Sponsor
- Center for Addiction and Mental Health
- Start
- Feb 2023
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of liquid metformin (Aspargo Labs) in obesity, sponsored by Center for Addiction and Mental Health. Started Feb 2023; status: recruiting.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
obesity
Beyond the preview
Go deeper on NCT05744479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05744479.